SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-24-236694
Filing Date
2024-10-11
Accepted
2024-10-11 16:53:07
Documents
13
Period of Report
2024-10-11

Document Format Files

Seq Description Document Type Size
1 PRE 14A d838871dpre14a.htm PRE 14A 333374
2 GRAPHIC g838871g10a01.jpg GRAPHIC 37032
3 GRAPHIC g838871g10a02.jpg GRAPHIC 2493
4 GRAPHIC g838871g10a03.jpg GRAPHIC 11587
5 GRAPHIC g838871g10a04.jpg GRAPHIC 1809
6 GRAPHIC g838871g10a05.jpg GRAPHIC 1846
7 GRAPHIC g838871g10a06.jpg GRAPHIC 4406
8 GRAPHIC g838871g10a08.jpg GRAPHIC 3139
9 GRAPHIC g838871g10a09.jpg GRAPHIC 12284
10 GRAPHIC g838871g10a10.jpg GRAPHIC 11015
11 GRAPHIC g838871g10t14.jpg GRAPHIC 15749
12 GRAPHIC g838871g36w34.jpg GRAPHIC 29463
13 GRAPHIC g838871g59c16.jpg GRAPHIC 28177
  Complete submission text file 0001193125-24-236694.txt   550836
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39267 | Film No.: 241368065
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)